Some potential molecular targets for therapy in gastric cancer have been reported in previous studies, such as EGFR (epidermal growth factor receptor) [3], VEGF (vascular endothelial growth factor) [4] and RON (recepteur d’origine nantais) [5]. Here, VEGFA is linked to gastric cancer.